The antifungal treatment market is poised for substantial expansion over the coming decade, driven by escalating global health challenges related to fungal pathogens and increasing recognition of mycoses as significant contributors to morbidity and mortality. Forecasting models indicate robust compound annual growth rates as pharmaceutical companies intensify efforts to develop...